Neudle.com: Alzheimer s disease screening

Differential
(Click to cross reference)

abiotrophy

abscess, intracerebral

abscess, intracranial-fungal

acetylcholine receptor

acetylcholinesterase

acetyl-L-carnitine

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acquired immunodeficiency syndrome, older adults

activated protein C resistance

activities of daily living

activities of daily living scale

addiction, heroin

aducanumab

advance directives

advances in neurology

adverse drug reaction

aerobic exercise

age associated memory impairment

alcohol, neurologic complications with

Alzheimer type II astrocytosis

Alzheimer's disease

Alzheimer's disease associated protein

Alzheimer's disease, age of onset

Alzheimer's disease, behavioral symptoms

Alzheimer's disease, conjugal

Alzheimer's disease, diagnosis of

Alzheimer's disease, driving with

Alzheimer's disease, early onset

Alzheimer's disease, early symptoms

Alzheimer's disease, familial

Alzheimer's disease, familial, late onset

Alzheimer's disease, heterogeneity of

Alzheimer's disease, incidence

Alzheimer's disease, misdiagnosis

Alzheimer's disease, noncognitive symptoms

Alzheimer's disease, pathogenesis

Alzheimer's disease, patient awareness of

Alzheimer's disease, preclinical

Alzheimer's disease, prognosis of

Alzheimer's disease, rapidly progressive

Alzheimer's disease, rate of clinical decline

Alzheimer's disease, risk factors in

Alzheimer's disease, staging

Alzheimer's disease, telling patient diagnosis of

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

Alzheimer's disease, vaccine

Alzheimer's disease, visual variant

amyloid angiopathy, cerebral

amyloid beta protein

amyloid beta protein antibodies

amyloid-related imaging abnormalities

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, epidemiology of

amyotrophic lateral sclerosis, familial

amyotrophic lateral sclerosis, guamian type of

anatomy of

aneuploidy

aneurysm, intracranial, familial

angiitis, isolated of CNS

angiotensin II receptor blocker

anticardiolipin antibodies

anticholinergic drugs

anticholinesterase

anticoagulant, treatment

antiphospholipid antibodies

antithrombin III deficiency

aphasia, classification of

aphasia, logopenic, progressive

aphasia, progressive

aphasia, progressive, non-fluent

aphasia, progressive, primary

aphasia, transcortical

aphasia, transcortical-sensory

apolipoprotein E

apolipoprotein E, false positive

apoliprotein E, plasma level

apraxia, constructional

arterial dissection

arterial dissection, carotid

arthrogryposis multiplex

autonomic dysfunction

bacterial infection

Balint's syndrome

basal ganglia, lesion of

basilar artery migraine

behavior

behavior modification

behavior, combative

behavioral disorder

Behcet's syndrome

benign essential tremor

benign senescent forgetfulness

benzodiazepine

beta adrenergic blocker

blood dyscrasias, neurologic findings with

brain transplantation

cardiac arrest and resuscitation

cardiomyopathy

caregiver

carotid artery stenosis

CAT scan

CAT scan, abnormal

CAT scan, delta sign, empty

CAT scan, dementia

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, indications for

CAT scan, normal ventricular size with aging

CAT scan, venography

cataplexy

cavum septi pellucidi

cell fusion test

central core disease

central nervous system, infection of

central pontine myelinolysis

cerebellar plaques, amyloid

cerebral blood flow

cerebral cortical atrophy

cerebral death

cerebral dominance

cerebral edema

cerebral edema, vasogenic

cerebral embolism

cerebral glucose metabolism

cerebral hemisphere left-right asymmetry

cerebral infarction

cerebral ischemia

cerebral venous infarction

cerebral venous thrombosis

cerebral venous thrombosis, deep

cerebral venous thrombosis, etiology

cerebral venous thrombosis, recurrent

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, biochemical markers of CNS disease

cerebrospinal fluid, enzymes in

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, hydroxyindoleacetic acid, 5(5-HIAA)

cerebrospinal fluid, oligoclonal IgG in

cerebrospinal fluid, serotonin

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, cost of

cerebrovascular accident, familial occurrence

cerebrovascular accident, infancy and childhood

cerebrovascular accident, multiple

cerebrovascular accident, prevention of

cerebrovascular accident, recurrent

cerebrovascular accident, silent

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular accident, young adult

cerebrovascular disease

cerebrovascular disease, risk factors in

cerebrovascular disease, treatment of

Charcot-Marie-Tooth

Charles Bonnet's syndrome

chelation therapy

chemonecrosis

chemotherapy, CNS treatment and complications with

children

chloroquine

cholesterol

choline acetyltransferase

chromosomal abnormality

chronic fatigue syndrome

cigarette smoking

cinnarizine

cisternogram, radionuclide

citalopram

claustrophobia

clindamycin

Clinical Pathologic Conference(C.P.C.)

color vision, impaired

color vision, impaired, cerebral

comorbidities

competency

complications

comprehension, impaired

compulsivity

conflict of interest

confusion

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

corpus callosum

corpus callosum, atrophy of

corpus callosum, neoplasm of

cortical blindness

cortical-basal ganglionic degeneration

corticotropin-releasing factor

craniectomy, decompressive

crying, pathologic

cultured skin fibroblasts

degenerative diseases of CNS

dementia, age at onset

dementia, cerebrovascular disease causing

dementia, clinical diagnosis

dementia, diagnostic classification

dementia, diagnostic evaluation of

dementia, differential diagnosis of

dementia, driving with

dementia, early detection

dementia, familial

dementia, frontal lobe type

dementia, frontotemporal

dementia, incidence

dementia, mixed

dementia, posttraumatic

dementia, preexisting in stroke patient

dementia, presenile

dementia, prevalence of

dementia, prevention of

dementia, rapidly progressive

dementia, reversible

dementia, screening for

dementia, transmissible

dementia, treatment of

dementia, unknown etiology

denial of illness

deprenyl

depression

depth perception, impaired

developmental milestones, loss of

differential diagnosis

dihydroepiandosterone

dimebon

dipyridamole

disability rating scale, neurological

disability, neurological

disease modifying agents

disseminated intravascular coagulation(DIC)

dopamine beta hydroxylase

drug induced neurologic disorders

drug interactions

drug withdrawal

dural sinus thrombosis

dysexecutive syndrome

dyskinesia, buccal lingual facial

dystonia, drug induced

dystonic reaction, acute

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, focal delta activity

electroencephalogram, periodic complexes

electroencephalogram, spike activity

electromagnetic fields

electron microscopy

electronic monitoring

encephalitis, autoimmune

encephalitis, viral

encephalopathy

encephalopathy, anoxic

encephalopathy, Hashimoto's

encephalopathy, metabolic

endocarditis, native-valve

enzyme, muscle disease

epidemiology of neurology

epsilon-aminocaproic acid(E.A.C.A.)

ethics in neurology

evidence-based research

evoked potentials

excitotoxin

executive dysfunction

exercise

expert witness, medical

eye movement, disorders of

Fazio-Londe's disease

fever

fibrinolytic agents

fibrinolytic agents, intra-venous local infusion

fibrinolytic agents, utilization

football neurologic injuries

foreign accent syndrome

fracture, long bone

Friedreich's ataxia

frontal behavioral spatial syndrome

frontal lobe, anatomy and physiology

frontal lobe, behavior with disease of

frontal lobe, lesion of

frontal lobe, pathologic signs of

frontotemporal dementia, behavioral variant

fungal infection, CNS

gastrostomy, percutaneous endoscopic

gaze palsy

gaze palsy, horizontal

gaze palsy, supranuclear

genetic neurologic disorders

genetic screening

genetic testing

Gerstmann syndrome

Gerstmann-Straussler-Scheinker disease

Gilles de la Tourette syndrome

glioblastoma multiforme(astrocytoma Gr.III)

glioma

globus pallidus

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

glutamic acid

GPS tracking

granulovacuolar degeneration

grasping

gray matter

Hallervorden Spatz disease

hallucination

hallucination, auditory

hallucination, visual

hallucination, visual, benign

haloperidol

handedness

head injury

head injury, hydrocephalus following

head injury, pediatric

heavy metal intoxication

hemianopia

hemianopia, homonymous

hemianopia, isolated homonymous

hemiparesis

hemoglobin abnormality, neurologic complications of

hemorrhagic diathesis

hemosiderosis of CNS, superficial

hemosiderosis, subarachnoid

hepatic failure

hepatitis

hepatosplenomegaly

heralding manifestation

herbs

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

histamine-2 receptor blockers

histochemistry

HMGcoA reductase inhibitors

human immunodeficiency virus type 1

hydrocephalus, normal pressure

hyperpyrexia, CNS disorder causing

hyperreflexia

hypertension

hypertension, cerebrovascular disease with

hypotension, systemic

hypoxia

hypoxic encephalopathy

iatrogenic neurologic disorders

imbalance, postural

immunization, neurologic complications with

immunoperoxidase staining

immunosuppression

inappropriate behavior

inattention

incidence

inclusion bodies

inclusion bodies, eosinophilic cytoplasmic

inclusion bodies, intracytopasmic

inclusion bodies, intranuclear

inclusion bodies, location of

incoordination

indomethacin

industrial neurologic disorders

infantile hemiplegia

infection

inflexibility, mental

intellectual deterioration

interferon

interobserver agreement

intracerebral hemorrhage

intracerebral hemorrhage, small

intracranial hypertension, benign

intracranial pressure, increased

intranasal medication

Jakob-Creutzfeldt disease

Jakob-Creutzfeldt disease, medical precaution with

jaundice

judgement, impaired

Kluver-Bucy syndrome

Kugelberg-Welander syndrome

laboratory values, normal

lacunar infarction

lacunar state

language disorder in adults

L-dopa

L-dopa, drug interactions with and side effects of

lead poisoning

lecanemab

lecithin

left-right orientation

leukemia, neurologic findings assoc.with

leuko-araiosis

leukoencephalitis, acute necrotizing hemorrhagic

leukoencephalopathy

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

life expectancy

life support, withdrawal of

lifestyle

limbic encephalitis

limbic system

limbic-predominant age-related TDP-43 encephalopathy

line bisection task

lipid lowering agent

lipid storage disorder of CNS

liver function enzymes

liver transplantation

lobar atrophy

locus ceruleus, lesion of

lymphoma involving CNS

machine learning

managed care

manganese intoxication

manic-depressive

marital status

medical-legal aspects of neurology

medication withdrawal

memantine

memory

memory enhancement

Memory Impairment Screen

memory, defect of recent

memory, disorder, treatment of

memory, evaluation of

memory, impairment of

memory, impairment of, isolated

memory, impairment of, subjective

mental status, abnormal

mental status, evaluation of

mesial temporal lobe

metrifonate

microhemorrhage, intracerebral

microtubule

middle cerebral artery territory infarction

middle cerebral artery, occlusion of

migraine

mild cognitive impairment

mild cognitive impairment converting to Alzheimer's disease

mimics

Mini Mental Status Examination

misdiagnosis

misdirection

misidentification

mitochondrial disease

molecular genetics

mongolism

monoamine oxidase inhibitors

monoclonal antibodies

movement disorder, drug induced

movement disorder, extrapyramidal

MRI

MRI, abnormal

MRI, CAT scan compared to

MRI, cerebrovascular disease

MRI, contrast enhanced

MRI, disappearing lesion on

MRI, false negative

MRI, field strength, high

MRI, voxel-based morphometry

MRS

multiple sclerosis

multiple sclerosis, diagnosis of

multiple system atrophy

muscle weakness, causes of

muscular dystrophy

muscular dystrophy, Duchenne

mutism

myasthenia gravis

myeloproliferative disorder

myopathy, drug-induced

myopathy, hypokalemic

myopathy, proximal

myopathy, steroid induced

neoplasm, intracranial

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

nerve growth factor

neurofibrillary degeneration

neurofibrillary degeneration, causes of

neurofibromatosis 1

neurofibromatosis 2

neurofilament light chain protein

neuroleptic

neuroleptic, atypical

neurologic complications of, systemic disease

neurologic consultation

neurologic disease

neurologic disease, diagnoses of

neurologic disease, tempo

neurologic evaluation

neurologic examination

neurologic examination, focal

neuron specific enolase

neuronal ceroid-lipofuscinosis

neuronal degeneration

neuronal loss

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy

neuropathy, amyloid

neuroprotective agents

non-dominant hemisphere

nonsteroidal anti-inflammatory drug

nucleus basalis of Meynert

nursing home

nylidrin

obsessive-compulsive disorder

occupational neurologic disorders

olanzapine

old age, driving and

old age, neurology of

olfactory bulb

opportunistic infection

opportunistic infection, CNS

optic atrophy

optic nerve, lesion of

optic neuropathy

oral contraceptives

oral contraceptives, cerbrovascular disease and

oral contraceptives, neurologic complications with

organ transplantation

orthostatic hypotension

osteoporosis

pain, abdominal

pain, increased response

parietal lobe, atrophy

parietal lobe, lesion of

parietal lobe, syndromes of

Parkinson disease

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, drug induced

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, heterogeneity of

Parkinson disease, L-dopa nonresponsive

Parkinson disease, misdiagnosis

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

paroxysmal nocturnal hemoglobinuria

PAS positive material in the brain

pathologic reflex

pathology

patient information and support

peduncular hallucinosis

peptides, brain

perhexiline maleate

perihippocampal fissure

perimetry

perimetry, computerized

persistent vegetative state

persistent vegetative state, children

persistent vegetative state, etiology of

Pittsburgh Compound B

placebo

plasminogen deficiency

platelet inhibiting drugs

pleocytosis of cerebrospinal fluid

pneumoencephalogram(PEG)

pneumonia

poison, mercury

poison, neurologic problems with

polycythemia, primary

polyneuropathy

polysomnogram

posterior cerebral artery occlusion

posterior cortical atrophy

posterior leukoencephalopathy syndrome

postural abnormality

potassium channel antibodies

practice guidelines

preclinical

pregnancy, neurologic complications in

prevention of neurologic disorders

primary thrombocythemia

prion disease

progesterone

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

progressive supranuclear palsy

protein 14-3-3, cerebrospinal fluid

protein 14-3-3, cerebrospinal fluid, false positive

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

psychomotor retardation

pupil, abnormality in neurologic disorders

radiation therapy, CNS treatment and complications with

radiotracer imaging

rapidly progressing neurologic illness

reading

reading disorder, acquired

reading problem, causes of

recombinant DNA

recurrent

Red flags

reduplicative paramnesia

release phenomena

REM sleep

remote effect of cancer on the nervous system

remternetug

repetitive questioning

research

retinal degeneration

reversible cerebral vasoconstrictive syndromes

reversible neurologic disorder

rheumatoid arthritis, neurologic complications of

rhinorrhea, CSF

rigidity

risk factors

risk factors, modification

risk-benefit assessment

salivation, excessive

seizure, diagnosis of

seizure, psychomotor-temporal lobe

seizure, risk factors for

seizure, surgical treatment of

selective serotonin reuptake inhibitors

serologic testing of cerebrospinal fluid

serotonin

sertraline

serum alanine aminotransferase

sexual behavior, disorder of

shadowing

shared decision making

single photon emission computed tomography

single photon emission computed tomography, false negative

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

skin, lesions in neurologic disorders

sleep

sleep pathology and physiology

slow virus infection of CNS

smell

Smell Identification Test

snout reflex

sodium-glucoe cotransporter-2 inhibitors

speech disorder

speech, loss of

spinal cord, injury of

spinal muscular atrophy

spinocerebellar ataxia

spinocerebellar ataxia type 1

splenomegaly

spongy degeneration of brain

sports medicine, neurology of

staining reactions in neuropathology

statin therapy

stem cell transplantation

stereotyped behavior

steroid

steroid therapy, CNS treatment and complications with

stimulant drugs

stimulation, deep brain

stooped posture

straight sinus

stress, emotional

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

subacute sclerosing panencephalitis, adult onset

subarachnoid hemorrhage

superior sagittal sinus thrombosis

symmetric brain lesions

systemic exertion intolerance disease

temporal lobe, atrophy

temporal lobe, lesion

temporal lobe, lesion, bilateral

tetrahydroaminoacridine

thrombocytopenia

thrombophlebitis

thyroiditis

tissue plasminogen activator, intravenous

toxic encephalopathy

toxoplasmosis, CNS

TRAILBLAZER-ALZ trial

transient ischemic attack

transient ischemic attack, treatment of

trauma

trazodone

treatment of neurologic disorder

treatment, non-pharmacologic

trinucleotide repeats

vaccination, neurologic complications with

vasodilating agents in treatment of cerebrovascular disease

velnacrine

ventricular enlargement

vincamine

vincristine neurotoxicity

vinpocetine

viral infection

viral infection, CNS

visual acuity, decreased

visual evoked response

visual field defect

visual field testing

visual fields

visual fields, constricted

visuospatial disturbance

vitamin E

vitamin supplementation

vitamin therapy

walking, difficulty with

Werdnig-Hoffman disease

white matter disease, periventricular

whites

Williams syndrome

word-finding difficulty

workup

writing

Showing articles 200 to 250 of 760 << Previous Next >>

Alzheimer's Disease
NEJM 351:56-67, Cummings,J.L, 2004

The Efficacy of Donepezil in the Treatment of Neuropsychiatric Symptoms in Alzheimer Disease
Neurol 63:214-219,200, Holmes,C.,et al, 2004

Atypical Antipsychotic Drugs in the Treatment of Behavioural and Psychological Symptoms of Dementia: Systematic Review
BMJ 329:75-78, Lee,P.E.,et al, 2004

Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial
Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004

Conjugated Equine Estrogens and Incidence of Probable Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 291:2947-2958,3005, Shumaker,S.A.,et al, 2004

Economic Evaluation of Donepezil in Moderate to Severe Alzheimer Disease
Neurol 63:644-650, Feldman,H.,et al, 2004

Efficacy of Donepezil in Mild Cognitive Impairment
Neurol 63:651-657, Salloway,S.,et al, 2004

Driver Route-Following and Safety Errors in Early Alzheimer Disease
Neurol 63:832-837, Uc,E.Y.,et al, 2004

A Multimodal Assessment of Driving Performance in HIV Infection
Neurol 63:1417-1422, Marcotte,T.D.,et al, 2004

Progressive Posterior Cortical Dysfunction
Neurol 63:1175-1180, Renner,J.A.,et al, 2004

Clinical, Genetic, and Neuropathologic Characteristics of Posterior Cortical Atrophy
Neurol 63:1168-1174, Tang-Wai,D.F.,et al, 2004

Hyperinsulinemia and Risk of Alzheimer Disease
Neurol 63:1187-1192, Luchsinger,J.A.,et al, 2004

Memory Complaints in Nondemented Men Predict Future Pathologic Diagnosis of Alzheimer Disease
Neurol 63:1960-1961, Jorm,A.F.,et al, 2004

Mixed Dementia, Emerging Concepts and Therapeutic Implications
JAMA 292:2901-2908, Langa,K.M.,et al, 2004

Preclinical Alzheimer Disease
Neurol 63:2341-2347, Saxton,J.,et al, 2004

Neuro-Ophthalmic Findings in the Visual Variant of Alzheimers Disease
Ophthalmology 111:376-381, Lee,A.G. &Martin,C.O., 2004

Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody
Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004

Tolerability of Memantine in Combination with Cholinesterase Inhibitors in Dementia Therapy
Int Clin Psychopharm 18:81-85, Hartmann,S.& Mobius, H.J., 2003

Efficacy of Cholinesterase Inhibitors in the Treatment of Neuropsychiatric symptoms and Functional Impairment in Alzheimer Disease
JAMA 289:210-216, Trinh,N.,et al, 2003

Acetylcholinesterase Inhibitors for Vascular Dementia and Alzheimer's Disease Combined With Cerebrovascular Disease
Stroke 34:584-586, Bowler,J.V., 2003

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

Antioxidant Vitamin Intake and Risk of Alzheimer Disease
Arch Neurol 60:203-208, Luchsinger,J.A.,et al, 2003

Low Blood Pressure and Risk of Dementia in the Kungsholmen Project
Arch Neurol 60:223-228, Qiu,C.,et al, 2003

Neuronal Loss Is Greater in the Locus Coeruleus Than Nucleus Basalis and Substantia Nigra in Alzheimer and Parkinson Diseases
Arch Neurol 60:337-341, 320, Zarow,C.,et al, 2003

DHEA Treatment of Alzheimer's Disease
Neurol 60:1071-1076,1060, Wolkowitz,O.M.,et al, 2003

Memantine in Moderate-to-Severe Alzheimer's Disease
NEJM 348:1333-1341, Reisberg,B.,et al, 2003

Alzheimer's Disease and Parkinson's Disease
NEJM 348:1356-1364, Nussbaum,R.L. &Ellis,C.E., 2003

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women
JAMA 289:2651-2662,2717, Shumaker,S.A.,et al, 2003

Leisure Activities and the Risk of Dementia in the Elderly
NEJM 348:2508-2516, Verghese,J.,et al, 2003

Subacute Meningoencephalitis in a Subset of Patients with AD After AB42 Immunization
Neurol 61:46-54,7, Orgogozo,J.M.,et al, 2003

Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Arch Neurol 60:940-946,923, Morris,M.C.,et al, 2003

Early Alzheimer's Disease
NEJM 349:1056-1063, Kawas,C.H., 2003

End-of-Life Care and the Effects of Bereavement on Family Caregivers of Persons with Dementia
NEJM 349:1936-1942,1891, Schulz,R.,et al, 2003

Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003

Donepezil is Associated with Delayed Nursing Home Placement in Patients with Alzheimer's Disease
Am Geriatr Soc 51:937-944, Geldmacher,D.S.,et al, 2003

Exercise Plus Behavioral Management in Patients with Alzheimer's Disease
JAMA 290:2015-2022, Teri,L.,et al, 2003

Identification of New Presenilin Gene Mutations in Early-Onset Familial Alzheimer Disease
Arch Neurol 60:1541-1544,1521, Tedde,A.,et al, 2003

Loss of Calculation Abilities in Patients with Mild and Moderate Alzheimer Disease
Arch Neurol 60:1585-1589, Martin,R.C.,et al, 2003

The Topography of Metabolic Deficits in Posterior Cortical Atrophy (the Visual Variant of Alzheimers Disease) with FDG-PET
JNNP 74:1521-1529, Nestor,P.J.,et al, 2003

Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
NEJM 346:476-483, 466, Seshadri,S.,et al, 2002

Epilepsy Presenting as AD: Neuroimaging, Electroclinical Features, and Response to Treatment
Neurol 58:298-301, Hogh,P.,et al, 2002

Functional Deficits in Patients with Mild Cognitive Impairment
Neurol 58:758-764, Tabert,M.H.,et al, 2002

Alzheimer Disease
JAMA 287:2335-2338, Cummings,J.L. &Cole,G., 2002

Utility of Clinical Criteria in Differentiating Frontotemporal Lobar Degeneration (FTLD) From AD
Neurol 58:1608-1615, Rosen,H.J.,et al, 2002

Natural History of Mild Cognitive Impairment in Older Persons
Neurol 59:198-205, Bennett,D.A.,et al, 2002

Potentially Reversible Conditions in 1000 Consecutive Memory Clinic Patients
JNNP 73:390-394, Hejl,A.,et al, 2002

Reduced Incidence of AD with NSAID But Not H2 Receptor Antagonists
Neurol 59:880-886, Zandi,P.P.,et al, 2002

Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment
JAMA 288:1475-1483, Lyketsos,C.G.,et al, 2002

Hormone Replacement Therapy and Incidence of Alzheimer Disease in Older Women
JAMA 288:2123-2129,2170, Zandi,P.P.,et al, 2002

Incidence and Outcome of Mild Cognitive Impairment in a Population-Based Prospective Cohort
Neurol 59;1594-1599, Larrieu,S.,et al, 2002

Showing articles 200 to 250 of 760 << Previous Next >>